Athersys Inc.

(ATHX) Trade

By |

Profile

Athersys Inc is a clinical stage biotechnology company. It is focused on developing novel and proprietary therapies in the areas where there is significant unmet medical need, particularly in the regenerative medicine area. The firm's main product is Multistem cell therapy. Its current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders and certain pulmonary conditions. Its revenue has been derived from corporate collaborations, license agreements, and government grants.

Contact Information

Website: www.athersys.com
Email: info@athersys.com
Main Phone: +1 216 431-9900
Address: 3201 Carnegie Avenue
State: OH
City / Town: Cleveland
Country: USA
Postal Code: 44115-2634

Issuer Information

Exchange: NSC
CEO: Gil Van Bokkelen
Employees: 75
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

Athersys Inc is a clinical stage biotechnology company. It is focused on developing novel and proprietary therapies in the areas where there is significant unmet medical need, particularly in the regenerative medicine area. The firm's main product is Multistem cell therapy. Its current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders and certain pulmonary conditions. Its revenue has been derived from corporate collaborations, license agreements, and government grants.

Contact Information

Website: www.athersys.com
Email: info@athersys.com
Main Phone: +1 216 431-9900
Address: 3201 Carnegie Avenue
State: OH
City / Town: Cleveland
Country: USA
Postal Code: 44115-2634

Issuer Information

Exchange: NSC
CEO: Gil Van Bokkelen
Employees: 75
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 1.40 $ -0.01 (-0.71%)
Last Price 1.40 Change $ -0.01 Change % -0.71 Tick N/A
Bid 1.40 Bid Size 5,000.00 Ask 1.41 Ask Size 5,400.00
Open 1.44 High 1.44 Low 1.36 Prev Close 1.41
Last Trade Volume 401,707 52 Wk Hi 2.23 52 Wk Low 1.20
Market Cap 213.7 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 152,677,751.00 EPS (TTM) -0.30 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 1 21
Number of Buys 0 0
Number of Sells 1 21
Net Activity -14000 -190898
Last 10 Buys Shares
Kenneth H. Traub 1,000
Kenneth H. Traub 1,000
Kenneth H. Traub 1,000
Kenneth H. Traub 1,000
Kenneth H. Traub 1,000
Kenneth H. Traub 1,000
Laura K. Campbell 1,000
Robert Deans 1,000
Robert Deans 1,000
Robert Deans 1,000
Last 10 Sell Shares
William Lehmann 1,000
John J. Harrington 1,000
John J. Harrington 1,000
William Lehmann 1,000
John J. Harrington 1,000
John J. Harrington 1,000
William Lehmann 1,000
John J. Harrington 1,000
John J. Harrington 1,000
John J. Harrington 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 6 6 6 6
Low Target Price Estimate 6 6 6 6
Mean Target Price Estimate 6 6 6 6
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 04/05/18 04/05/18 04/05/18 04/05/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1